Updated:
Sigma Square Capital
SIGMA SQUARE CAPITAL is an investment institution focused on high-growth emerging industries. It invests in early-stage companies in healthcare, technology,...
Sigma Square Capital
SIGMA SQUARE CAPITAL is an investment institution focused on high-growth emerging industries. It invests in early-stage companies in healthcare, technology, finance, and consumer products. The firm has made 16 investments, including a Series C investment in ABclonal on December 18, 2020.
General information
Firm type
Private Equity
Year founded
2015
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Frequently asked questions
Where does Sigma Square Capital deploy capital geographically?
Sigma Square Capital is headquartered in Beijing, China, and its strategy is focused on the domestic Chinese market. There is no public record of international offices or cross-border investments. The Beijing location places the firm within China's primary venture capital hub.
Does Sigma Square Capital co-invest alongside other GPs?
Public record contains no information on co-investment activity, syndication partners, or participation in club deals. The firm's visibility in deal databases is minimal, making its collaborative investment posture unknown without direct disclosure.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: